BVS Q2 2021 Earnings — Bioventus Inc. Revenue & Financial Results | Market Cap Arena

BVSBioventus Inc.

$593M

Q2 2021 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$110M+89.3% YoY

Gross Profit

$76M69.5% margin

Operating Income

-$6M-5.2% margin

Net Income

-$4M-3.8% margin

EPS (Diluted)

$-0.10

QoQ Revenue Growth

+34.3%

Cash Flow

Operating Cash Flow

$17M

Free Cash Flow

$16M

Stock-Based Comp.

$6M

Balance Sheet

Total Assets

$647M

Total Liabilities

$427M

Stockholders' Equity

$142M

Cash & Equivalents

$136M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$110M	$58M	+89.3%
Gross Profit	$76M	$40M	+89.1%
Operating Income	-$6M	-$5M	-25.0%
Net Income	-$4M	-$6M	+28.4%

Revenue Segments

Pain Treatments And Joint Preservation

$57M52%

Restorative Therapies

$33M30%

Bone Graft Substitutes

$21M19%

Geographic Segments

UNITED STATES

$99M90%

Non-US

$11M10%